newdrugapprovals.org
FDA approves first treatment Gamifant (emapalumab) specifically for patients with rare and life-threatening type of immune disease
FDA approves first treatment Gamifant (emapalumab) specifically for patients with rare and life-threatening type of immune disease The U.S. Food and Drug Administration today approved Gamifant (e…